These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3858978)

  • 21. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
    Salmon J; Coussediere D; Cousty C; Raynaud JP
    J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolism and kinetics of doxazosin in man, mouse, rat and dog.
    Kaye B; Cussans NJ; Faulkner JK; Stopher DA; Reid JL
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):19S-25S. PubMed ID: 2939865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of proton pump inhibitors in children.
    Litalien C; Théorêt Y; Faure C
    Clin Pharmacokinet; 2005; 44(5):441-66. PubMed ID: 15871633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic fate of a new anti-ulcer drug (+)-(1R,4aS,10aR)- 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1- methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate (TA-2711). I. Disposition, metabolism and protein binding in rats and dogs.
    Ito Y; Fukushima T; Sugawara Y; Takaiti O; Nakamura S
    J Pharmacobiodyn; 1991 Sep; 14(9):533-46. PubMed ID: 1779408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic profile of nicorandil in humans: an overview.
    Frydman A
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S34-44. PubMed ID: 1282174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.
    Hawkins DR; Weston KT; Chasseaud LF; Darragh A; O'Kelly A
    Eur J Drug Metab Pharmacokinet; 1980; 5(3):135-43. PubMed ID: 7202431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats.
    Kong XB; Vidal P; Tong WP; Chiang J; Gloff CA; Chou TC
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1472-7. PubMed ID: 1510443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of omeprazole and metabolites in the mouse.
    Helander HF; Ramsay CH; Regårdh CG
    Scand J Gastroenterol Suppl; 1985; 108():95-104. PubMed ID: 3858979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration.
    Chadwick M; Silveira DM; MacGregor JA; Branfman AR; Liss RH; Yesair DW
    Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolism of the hypolipidaemic drug sultosilic acid in rat, dog and man.
    Wood SG; Kirkpatrick D; Jackson AJ; Hawkins DR; Down WH; Chasseaud LF; Biggs SR; Darragh A
    Xenobiotica; 1982 Mar; 12(3):165-76. PubMed ID: 7113253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of [14C]omeprazole in patients with impaired renal function.
    Naesdal J; Andersson T; Bodemar G; Larsson R; Regårdh CG; Skånberg I; Walan A
    Clin Pharmacol Ther; 1986 Sep; 40(3):344-51. PubMed ID: 3742939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral pharmacokinetics of omeprazole.
    Howden CW; Meredith PA; Forrest JA; Reid JL
    Eur J Clin Pharmacol; 1984; 26(5):641-3. PubMed ID: 6468483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.